The results showed that several genes are associated with cancer incidence: AKT1 is connected with endometrial cancer [26]; CD44 is associated with progression-free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel [27]; CDH1 shows an association with colorectal cancer, as reported in two studies [28,29]; COL1A1 is related to BC [30]; COL4A5 is associated with non-melanoma skin cancer [31]; EGFR reveals an connection with BC [32]; LAMA3 is associated with ovarian carcinoma [33]; and TUBB is linked to cervical carcinoma [34]. This evidence concerns the gene CD44 and cancer.